90 related articles for article (PubMed ID: 10078253)
1. On-line cell manipulation for cancer treatment.
Tani T; Numa K; Abe H; Yokota T; Kodama M
Artif Organs; 1992 Jun; 16(3):243-7. PubMed ID: 10078253
[TBL] [Abstract][Full Text] [Related]
2. Induction of antitumor activities in spleen cells from mice and rats activated with lipopolysaccharide immobilized on beads.
Abe H; Tani T; Shibata J; Kodama M
Cancer Immunol Immunother; 1992; 35(1):39-45. PubMed ID: 1611621
[TBL] [Abstract][Full Text] [Related]
3. [Antitumor effect of LPS immobilized beads].
Abe H
Nihon Geka Gakkai Zasshi; 1991 Jun; 92(6):627-35. PubMed ID: 1886567
[TBL] [Abstract][Full Text] [Related]
4. Basic studies on a new material for inducing antitumor immune cells.
Yamazaki Z; Hiraishi M; Kanai F; Takahama T; Idezuki Y; Yasuda K; Ohsawa Y; Sugawara T; Watanabe H; Inagaki K
ASAIO Trans; 1990; 36(3):M209-11. PubMed ID: 2252659
[TBL] [Abstract][Full Text] [Related]
5. Lectin-activated killer cells rapidly induced by pokeweed mitogen conjugated beads and their in vivo antitumor effects.
Ohno S; Tanaka N; Hizuta A; Miyagi K; Orita K
Int J Immunopharmacol; 1994 Sep; 16(9):761-8. PubMed ID: 7806434
[TBL] [Abstract][Full Text] [Related]
6. Polyethylene glycol-modified pokeweed mitogen (PWM) as a potential non-immunogenic stimulator of lymphokine-activated killer cells.
Ueno T; Kodera Y; Kimoto Y; Sakurai K; Hiroto M; Matsushima A; Nishimura H; Takai S; Inada Y
J Biomater Sci Polym Ed; 1996; 7(9):753-8. PubMed ID: 8773879
[TBL] [Abstract][Full Text] [Related]
7. Use of human leukocyte antigen-mismatched allogeneic lymphokine-activated killer cells and interleukin-2 in the adoptive immunotherapy of patients with malignancies.
Kimoto Y
Hum Cell; 1992 Sep; 5(3):226-35. PubMed ID: 1467321
[TBL] [Abstract][Full Text] [Related]
8. Human lymphokine-activated killer cells suppress pokeweed mitogen-induced immunoglobulin synthesis.
Suzuki H; Yamashita N; Maruyama M; Yoshikawa T; Yano S
Clin Exp Immunol; 1989 Dec; 78(3):406-11. PubMed ID: 2532992
[TBL] [Abstract][Full Text] [Related]
9. Trial of anticancer immunotherapy with immobilized pokeweed mitogen: immunotherapy by extracorporeal circulation.
Numa K; Tani T; Kodama M
Cancer Immunol Immunother; 1990; 32(2):125-30. PubMed ID: 2289204
[TBL] [Abstract][Full Text] [Related]
10. Inhibition and potentiation of T lymphocyte response to mitogens. Studies using two mitogenic stimuli simultaneously.
Franceschi C; Cevolani C; Licastro F; Paolucci P; Prodi G; Perocco P
Arch Sci Biol (Bologna); 1978; 62(1-4):139-54. PubMed ID: 400233
[TBL] [Abstract][Full Text] [Related]
11. [Induction of lymphokine activated killer (LAK) and prolongation of its activity by intrasplenic injection of interleukin 2 (IL-2) in combination with tumor necrosis factor (TNF)].
Nakajima I; Okuno K; Ohnishi H; Shilayama Y; Nakamura T; Hirohata T; Yasutomi M
Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1548-53. PubMed ID: 2263237
[TBL] [Abstract][Full Text] [Related]
12. [Apoptosis of tumor cells in lectin-dependent lymphokine-activated killer cell-mediated cytotoxicity].
Dong H; Xing R; Guo L
Zhonghua Zhong Liu Za Zhi; 1995 Jul; 17(4):245-8. PubMed ID: 7587887
[TBL] [Abstract][Full Text] [Related]
13. Lymphokine-activated killer (LAK) cell activity in tumor-infiltrating lymphocytes from non-small cell lung cancer.
Pisani RJ; Krco CJ; Wold LE; McKean DJ
Am J Clin Pathol; 1989 Oct; 92(4):435-46. PubMed ID: 2552792
[TBL] [Abstract][Full Text] [Related]
14. Immunoregulatory properties of (+)-pentazocine and sigma ligands.
Carr DJ; Mayo S; Woolley TW; DeCosta BR
Immunology; 1992 Dec; 77(4):527-31. PubMed ID: 1493925
[TBL] [Abstract][Full Text] [Related]
15. Effect of macrophages on interleukin-2 (IL-2)- and IL-4-induced murine lymphokine-activated killer activity.
Tunru IS; Suzuki H; Yano S
Int J Cancer; 1991 Jun; 48(4):568-73. PubMed ID: 2045201
[TBL] [Abstract][Full Text] [Related]
16. Resistance of different tumor cells to lysis by lymphokine activated killer cells can be mediated by distinct mechanisms.
Bean P; Mazumder A
Immunobiology; 1992 Jun; 185(1):63-77. PubMed ID: 1398742
[TBL] [Abstract][Full Text] [Related]
17. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
[TBL] [Abstract][Full Text] [Related]
18. [In vivo antitumor effect of LAK cells induced from various lymphocytes--experimental study in rats].
Goshima H; Saji S; Tanemura H; Takao H; Tachibana S; Oiwa T; Keshikawa I
Nihon Geka Gakkai Zasshi; 1989 Jul; 90(7):972-9. PubMed ID: 2796984
[TBL] [Abstract][Full Text] [Related]
19. In vivo migration and tissue localization of highly purified lymphokine-activated killer cells (A-LAK cells) in tumor-bearing rats.
Felgar RE; Hiserodt JC
Cell Immunol; 1990 Sep; 129(2):288-98. PubMed ID: 2383892
[TBL] [Abstract][Full Text] [Related]
20. In vitro tumour cell growth inhibition: a comparative study between allosensitized cytotoxic T lymphocytes and lymphokine activated killer cells.
Fuggetta MP; Alvino E; Pepponi R; De Filippi R; Marini S; Bonmassar E
Cell Prolif; 1993 Jul; 26(4):305-16. PubMed ID: 8343559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
